查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1282920

原位雜交（ISH）市場-全球市場規模、份額、趨勢分析、機會、預測報告，2019-2029，按技術；按探針；按產品；按應用；按最終用途

In Situ Hybridization Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By Technology ; By Probe ; By Product ; By Application ; By End Use ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

原位雜交 (ISH) 全球市場規模到 2029 年將達到 32.6 億美元

全球原位雜交 (ISH) 市場的推動因素包括人們對 ISH 使用意識的不斷增強、醫療保健支出的增加、癌症患病率的增加以及對診斷癌症、染色體異常和傳染病的需求不斷增加。 ISH 在研究活動和實驗室中的應用正在蓬勃發展。

領先的戰略諮詢和市場研究公司 BlueWeave Consulting 最近估計 2022 年全球原位雜交 (ISH) 市場規模為 14.2 億美元。 BlueWeave 預測，2023-2029 年預測期內，全球原位雜交（ISH）市場規模將以 12.73% 的複合年增長率顯著增長，到 2029 年將達到 32.6 億美元的增長。 全球原位雜交（ISH）市場的一個關鍵增長動力是對分子診斷工具不斷增長的需求。 ISH 的使用增加是由於慢性病發病率上升和對快速診斷方法的需求不斷增長所致。 IVD領域的技術發展也是ISH市場的驅動因素之一。 高價值原位雜交（ISH）技術的發展以及原位雜交（ISH）在印度等新興國家的日益普及將帶來新的市場機遇。 然而，原位雜交（ISH）市場預計將受到探針成本高、FISH 檢測患者顯著異常的能力低以及檢測過程冗長的阻礙。 高通量全基因組測序、微陣列等先進技術的可用性也制約著全球原位雜交（ISH）市場的發展。

全球原位雜交 (ISH) 市場 - 概述：

原位雜交 (ISH) 是一種用於檢測細胞和組織中特定 DNA 或 RNA 序列的實驗室技術。 該技術使用與目標 DNA 或 RNA 序列互補的標記核酸探針。 探針設計用於特異性結合靶序列，從而能夠在所研究的細胞或組織內檢測和定位它們。 原位雜交可用於研究多種生物現象，例如基因表達、基因突變、染色體畸變和病毒感染。 該技術廣泛應用於癌症研究、發育生物學和神經科學等各個研究領域。

COVID-19 對全球原位雜交 (ISH) 市場的影響

COVID-19 大流行對原位雜交 (ISH) 市場產生了雙重影響。 一方面，疫情對供應鍊和製造流程的影響推遲了原位雜交（ISH）檢測和試劑的製造和交付。 這影響了這些產品的可及性和可用性，特別是在受大流行影響的地區。 與此同時，疫情增加了 COVID-19 研究中對原位雜交 (ISH) 方法的需求。 利用原位雜交（ISH）可以在組織和細胞中檢測到SARS-CoV-2病毒，並可以研究病毒的病理生理學和感染途徑。 因此，人們越來越有興趣使用原位雜交 (ISH) 作為 COVID-19 的研究和診斷工具。

全球原位雜交 (ISH) 市場 - 按產品：

按產品劃分，全球原位雜交 (ISH) 市場分為儀器、試劑盒和探針、軟件和服務。 到 2022 年，由於診斷實驗室和實驗室的需求不斷增加，原位雜交 (ISH) 市場將由儀器領域主導，預計在預測期內其增長將持續。 對更好的顯微鏡和成像系統的需求預計將成為需求的主要驅動力，這些系統能夠對 FISH、CISH 和 ISH 樣品進行更高質量的成像。 研究人員和病理學家青睞這些儀器，因為它們具有成本效益、易用性和便攜性等潛在優勢。 另一方面，試劑盒和探針領域預計在預測期內將出現顯著增長。 癌症等目標疾病發病率的增加預計將推動對這些產品的需求。 白血病、實體瘤、淋巴瘤和自閉症等遺傳性疾病的增加預計將推動 FISH 和 CISH 探針的採用。 未來的市場增長預計將由醫療保健支出的增加、新型探針的研發力度的加大以及對高靈敏度、快速和準確的診斷技術的需求推動。

競爭格局：

全球原位雜交 (ISH) 市場的主要公司有：Thermo Fisher Scientific Inc.、Abbott (Abbott Molecular)、PerkinElmer Inc.、BioView、Agilent Technologies, Inc.、 Merck KGaA、Bio-Rad Laboratories, Inc、Oxford Gene Technology IP Limited、Leica Biosystems Nussloch GmbH、F. Hoffman-La Roche Limited、NeoGenomics Laboratories, Inc 和 Advanced Cell Diagnostics, Inc. 為了進一步增加其市場份額，這些公司正在採取各種策略，如併購、合作、合資、許可協議和新產品發布。

本報告的詳細分析提供了有關全球原位雜交市場的增長潛力、未來趨勢和統計數據的信息。 它還涵蓋了推動市場總規模預測的因素。 該報告致力於提供全球原位雜交市場的最新技術趨勢以及行業見解，使決策者能夠做出明智的戰略決策。 它還分析了市場的增長動力、挑戰和競爭動態。

內容

第 1 章研究框架

第 2 章執行摘要

第 3 章全球原位雜交市場洞察

  • 行業價值鏈分析
  • DROC 分析
    • 增長動力
      • 目標疾病的患病率增加
      • 增加體外診斷的研發投入
    • 抑制因素
      • 存在不明確的監管框架
    • 機會
      • 人們對使用原位雜交的認識不斷增強
    • 任務
      • 需要先進技術的勞動密集型產品
  • 技術進步/最新發展
  • 監管框架
  • 波特五力分析

第 4 章全球原位雜交市場概述

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
      • 螢光原位雜交 (FISH)
      • 顯色原位雜交 (CISH)
    • 按探測
      • DNA RNA
    • 按產品
      • 工具
      • 試劑盒和探針
      • 軟件
      • 服務
    • 按用途
      • 癌症
      • 細胞遺傳學
      • 發育生物學
      • 感染
      • 其他
    • 按最終用途
      • 研究和診斷實驗室
      • 合同研究組織
      • 學術機構
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區 (APAC)
      • 拉丁美洲 (LATAM)
      • 中東和非洲 (MEA)

第 5 章北美原位雜交市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
    • 按探測
    • 按產品
    • 按用途
    • 按最終用途
    • 按國家/地區
      • 美國
      • 加拿大

第 6 章歐洲原位雜交市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
    • 按探測
    • 按產品
    • 按用途
    • 按最終用途
    • 按國家/地區
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 比利時
      • 俄羅斯
      • 荷蘭
      • 歐洲其他地區

第 7 章亞太原位雜交市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
    • 按探測
    • 按產品
    • 按用途
    • 按最終用途
    • 按國家/地區
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 越南
      • 亞太地區的其他國家/地區

第 8 章拉丁美洲原位雜交市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
    • 按探測
    • 按產品
    • 按用途
    • 按最終用途
    • 按國家/地區
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 其餘拉丁美洲地區

第 9 章中東和非洲原位雜交市場

  • 2019-2029 年市場規模和預測
    • 按金額
  • 市場份額和預測
    • 按技術
    • 按探測
    • 按產品
    • 按用途
    • 按最終用途
    • 按國家/地區
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 多邊環境協定的其餘部分

第 10 章競爭格局

  • 主要公司及其產品列表
  • 2022年全球原位雜交企業市場份額分析
  • 通過運行參數進行競爭基準測試
  • 重大戰略發展（合併、收購、合作夥伴關係等）

第 11 章 COVID-19 對全球原位雜交市場的影響

第 12 章公司簡介（公司簡介、財務矩陣、競爭格局、關鍵人才、主要競爭對手、聯繫地址、戰略展望、SWOT 分析）

  • Thermo Fisher Scientific Inc.
  • Abbott（Abbott Molecular）
  • PerkinElmer, Inc.
  • BioView
  • Agilent Technologies, Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Oxford Gene Technology IP Limited
  • Leica Biosystems Nussloch GmbH
  • F. Hoffman-La Roche Limited
  • NeoGenomics Laboratories, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Other Prominent Players

第 13 章關鍵戰略建議

第 14 章研究方法

  • 定性研究
    • 初級和次級研究
  • 定量研究
  • 市場細分和數據三角測量
    • 二次調查
    • 初步調查
  • 主要調查受訪者按地區細分
  • 假設和限制
簡介目錄
Product Code: BWC23423

Global In Situ Hybridization (ISH) Market Size Set to Touch USD 3.26 billion by 2029

Global in situ hybridization (ISH) market is flourishing because of rising awareness of the use of ISH, increasing levels of healthcare expenditures, growing cancer prevalence, and high adoption of ISH in research activities and laboratories to diagnose cancer, chromosomal abnormalities, and infectious diseases.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated global in situ hybridization (ISH) market size at USD 1.42 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects global in situ hybridization market size to grow at a significant CAGR of 12.73% reaching a value of USD 3.26 billion by 2029. Major growth drivers for the global in situ hybridization market include the rising need for molecular diagnostic tools. The expanding use of ISH is a result of both the rising incidence of chronic diseases and the growing demand for quick diagnostic methods. Technology developments in the IVD (in vitro diagnostics) sector are the other drivers of the ISH market. The development of high value in situ hybridization technologies and the expansion of in situ hybridization use in developing countries like India will provide new market opportunities. However, the in situ hybridization market is anticipated to be hampered by the high cost of probes, FISH's poor ability to detect significant patient abnormalities, and the lengthy detection processes. Also, the development of the global In Situ Hybridization (ISH) market is constrained by the availability of superior technologies, including high-throughput whole genome sequencing, microarray, and others.

Global In situ Hybridization Market - Overview:

In situ hybridization (ISH) is a laboratory technique used to detect specific DNA or RNA sequences in cells or tissues. The technique involves the use of a labelled nucleic acid probe that is complementary to the target DNA or RNA sequence. The probe is designed to bind specifically to the target sequence, allowing for its detection and localization within the cells or tissues under study. In situ hybridization can be used to study a wide range of biological phenomena, including gene expression, genetic mutations, chromosomal abnormalities, and viral infections. The technique is widely used in various fields of research, including cancer research, developmental biology, and neuroscience, among others.

Impact of COVID-19 on Global In situ Hybridization Market

COVID-19 pandemic had a dual impact on the market for in situ hybridization. On the one hand, the manufacturing and delivery of in situ hybridization assays and reagents were delayed due to the pandemic's impact on supply chains and manufacturing processes. This had an influence on the accessibility and availability of these products, especially in areas where the pandemic has had a significant impact. On the other hand, the pandemic enhanced the need for in situ hybridization methods in COVID-19 research. The SARS-CoV-2 virus may be found in tissues and cells using in situ hybridization, which can also be used to examine the pathophysiology and transmission of the virus. Consequently, there was an increasing interest in using in situ hybridization as a COVID-19 research and diagnostic tool.

Global In situ Hybridization Market - By Product:

Based on product, the global in situ hybridization market is segmented into Instruments, Kits & Probes, Software, and Services segments. In 2022, the instruments segment dominated the in situ Hybridization (ISH) market, and its growth is expected to continue during the forecast period due to the increasing demand from diagnostic and research laboratories. The need for better microscopes and imaging systems to enable higher quality imaging of FISH, CISH, and ISH samples is predicted to be a major driver of demand. Researchers and pathologists favor these instruments due to their potential benefits, such as greater cost-effectiveness, ease of use, and portability. Meanwhile, the kits and probes segment is expected to witness significant growth during the forecast period. The increasing incidence of target disorders like cancer is anticipated to drive demand for these products. The rise in genetic diseases such as leukemia, solid tumors, lymphoma, and autism is expected to boost the adoption of FISH and CISH probes. The market's future growth is projected to be driven by a rise in healthcare expenditure, an increase in R&D for the development of novel probes, and the demand for sensitive, rapid, and accurate diagnostic techniques.

Competitive Landscape:

Major players operating in the global in situ hybridization market include: Thermo Fisher Scientific Inc., Abbott (Abbott Molecular), PerkinElmer Inc., BioView, Agilent Technologies, Inc., Merck KGaA, Bio-Rad Laboratories, Inc., Oxford Gene Technology IP Limited, Leica Biosystems Nussloch GmbH, F. Hoffman-La Roche Limited, NeoGenomics Laboratories, Inc., and Advanced Cell Diagnostics, Inc. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The report's in-depth analysis provides information about growth potential, upcoming trends, and the Global In Situ Hybridization Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global In Situ Hybridization Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global In-Situ Hybridization Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Growing Prevalence of Target Disorders
      • 3.2.1.2. Rising R&D Investments in In-Vitro Diagnostics
    • 3.2.2. Restraints
      • 3.2.2.1. Presence of an Ambiguous Regulatory Framework
    • 3.2.3. Opportunities
      • 3.2.3.1. Growing Awareness About the In-Situ Hybridization Usage
    • 3.2.4. Challenges
      • 3.2.4.1. Highly Skilled Labor-Intensive Product
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global In-Situ Hybridization Market Overview

  • 4.1. Market Size & Forecast, 2019-2029
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Technology
      • 4.2.1.1. Fluorescent In-Situ Hybridization (FISH)
      • 4.2.1.2. Chromogenic In-Situ Hybridization (CISH)
    • 4.2.2. By Probe
      • 4.2.2.1. DNA
      • 4.2.2.2. RNA
    • 4.2.3. By Product
      • 4.2.3.1. Instruments
      • 4.2.3.2. Kits & Probes
      • 4.2.3.3. Software
      • 4.2.3.4. Services
    • 4.2.4. By Application
      • 4.2.4.1. Cancer
      • 4.2.4.2. Cytogenetics
      • 4.2.4.3. Developmental Biology
      • 4.2.4.4. Infectious Diseases
      • 4.2.4.5. Others
    • 4.2.5. By End Use
      • 4.2.5.1. Research & Diagnostic Laboratories
      • 4.2.5.2. CROs
      • 4.2.5.3. Academic Institutes
      • 4.2.5.4. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific (APAC)
      • 4.2.6.4. Latin America (LATAM)
      • 4.2.6.5. Middle East and Africa (MEA)

5. North America In-Situ Hybridization Market

  • 5.1. Market Size & Forecast, 2019-2029
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology
    • 5.2.2. By Probe
    • 5.2.3. By Product
    • 5.2.4. By Application
    • 5.2.5. By End Use
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Technology
      • 5.2.6.1.2. By Probe
      • 5.2.6.1.3. By Product
      • 5.2.6.1.4. By Application
      • 5.2.6.1.5. By End Use
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Technology
      • 5.2.6.2.2. By Probe
      • 5.2.6.2.3. By Product
      • 5.2.6.2.4. By Application
      • 5.2.6.2.5. By End Use

6. Europe In-Situ Hybridization Market

  • 6.1. Market Size & Forecast, 2019-2029
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Probe
    • 6.2.3. By Product
    • 6.2.4. By Application
    • 6.2.5. By End Use
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Technology
      • 6.2.6.1.2. By Probe
      • 6.2.6.1.3. By Product
      • 6.2.6.1.4. By Application
      • 6.2.6.1.5. By End Use
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Technology
      • 6.2.6.2.2. By Probe
      • 6.2.6.2.3. By Product
      • 6.2.6.2.4. By Application
      • 6.2.6.2.5. By End Use
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Technology
      • 6.2.6.3.2. By Probe
      • 6.2.6.3.3. By Product
      • 6.2.6.3.4. By Application
      • 6.2.6.3.5. By End Use
      • 6.2.6.4. France
      • 6.2.6.4.1. By Technology
      • 6.2.6.4.2. By Probe
      • 6.2.6.4.3. By Product
      • 6.2.6.4.4. By Application
      • 6.2.6.4.5. By End Use
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Technology
      • 6.2.6.5.2. By Probe
      • 6.2.6.5.3. By Product
      • 6.2.6.5.4. By Application
      • 6.2.6.5.5. By End Use
      • 6.2.6.6. Belgium
      • 6.2.6.6.1. By Technology
      • 6.2.6.6.2. By Probe
      • 6.2.6.6.3. By Product
      • 6.2.6.6.4. By Application
      • 6.2.6.6.5. By End Use
      • 6.2.6.7. Russia
      • 6.2.6.7.1. By Technology
      • 6.2.6.7.2. By Probe
      • 6.2.6.7.3. By Product
      • 6.2.6.7.4. By Application
      • 6.2.6.7.5. By End Use
      • 6.2.6.8. The Netherlands
      • 6.2.6.8.1. By Technology
      • 6.2.6.8.2. By Probe
      • 6.2.6.8.3. By Product
      • 6.2.6.8.4. By Application
      • 6.2.6.8.5. By End Use
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Technology
      • 6.2.6.9.2. By Probe
      • 6.2.6.9.3. By Product
      • 6.2.6.9.4. By Application
      • 6.2.6.9.5. By End Use

7. Asia-Pacific In-Situ Hybridization Market

  • 7.1. Market Size & Forecast, 2019-2029
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Probe
    • 7.2.3. By Product
    • 7.2.4. By Application
    • 7.2.5. By End Use
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Technology
      • 7.2.6.1.2. By Probe
      • 7.2.6.1.3. By Product
      • 7.2.6.1.4. By Application
      • 7.2.6.1.5. By End Use
      • 7.2.6.2. India
      • 7.2.6.2.1. By Technology
      • 7.2.6.2.2. By Probe
      • 7.2.6.2.3. By Product
      • 7.2.6.2.4. By Application
      • 7.2.6.2.5. By End Use
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Technology
      • 7.2.6.3.2. By Probe
      • 7.2.6.3.3. By Product
      • 7.2.6.3.4. By Application
      • 7.2.6.3.5. By End Use
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Technology
      • 7.2.6.4.2. By Probe
      • 7.2.6.4.3. By Product
      • 7.2.6.4.4. By Application
      • 7.2.6.4.5. By End Use
      • 7.2.6.5. Australia & New Zealand
      • 7.2.6.5.1. By Technology
      • 7.2.6.5.2. By Probe
      • 7.2.6.5.3. By Product
      • 7.2.6.5.4. By Application
      • 7.2.6.5.5. By End Use
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Technology
      • 7.2.6.6.2. By Probe
      • 7.2.6.6.3. By Product
      • 7.2.6.6.4. By Application
      • 7.2.6.6.5. By End Use
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Technology
      • 7.2.6.7.2. By Probe
      • 7.2.6.7.3. By Product
      • 7.2.6.7.4. By Application
      • 7.2.6.7.5. By End Use
      • 7.2.6.8. Singapore
      • 7.2.6.8.1. By Technology
      • 7.2.6.8.2. By Probe
      • 7.2.6.8.3. By Product
      • 7.2.6.8.4. By Application
      • 7.2.6.8.5. By End Use
      • 7.2.6.9. Vietnam
      • 7.2.6.9.1. By Technology
      • 7.2.6.9.2. By Probe
      • 7.2.6.9.3. By Product
      • 7.2.6.9.4. By Application
      • 7.2.6.9.5. By End Use
      • 7.2.6.10. Rest of APAC
      • 7.2.6.10.1. By Technology
      • 7.2.6.10.2. By Probe
      • 7.2.6.10.3. By Product
      • 7.2.6.10.4. By Application
      • 7.2.6.10.5. By End Use

8. Latin America In-Situ Hybridization Market

  • 8.1. Market Size & Forecast, 2019-2029
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Probe
    • 8.2.3. By Product
    • 8.2.4. By Application
    • 8.2.5. By End Use
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Technology
      • 8.2.6.1.2. By Probe
      • 8.2.6.1.3. By Product
      • 8.2.6.1.4. By Application
      • 8.2.6.1.5. By End Use
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Technology
      • 8.2.6.2.2. By Probe
      • 8.2.6.2.3. By Product
      • 8.2.6.2.4. By Application
      • 8.2.6.2.5. By End Use
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Technology
      • 8.2.6.3.2. By Probe
      • 8.2.6.3.3. By Product
      • 8.2.6.3.4. By Application
      • 8.2.6.3.5. By End Use
      • 8.2.6.4. Peru
      • 8.2.6.4.1. By Technology
      • 8.2.6.4.2. By Probe
      • 8.2.6.4.3. By Product
      • 8.2.6.4.4. By Application
      • 8.2.6.4.5. By End Use
      • 8.2.6.5. Rest of LATAM
      • 8.2.6.5.1. By Technology
      • 8.2.6.5.2. By Probe
      • 8.2.6.5.3. By Product
      • 8.2.6.5.4. By Application
      • 8.2.6.5.5. By End Use

9. Middle East & Africa In-Situ Hybridization Market

  • 9.1. Market Size & Forecast, 2019-2029
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Probe
    • 9.2.3. By Product
    • 9.2.4. By Application
    • 9.2.5. By End Use
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Technology
      • 9.2.6.1.2. By Probe
      • 9.2.6.1.3. By Product
      • 9.2.6.1.4. By Application
      • 9.2.6.1.5. By End Use
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Technology
      • 9.2.6.2.2. By Probe
      • 9.2.6.2.3. By Product
      • 9.2.6.2.4. By Application
      • 9.2.6.2.5. By End Use
      • 9.2.6.3. Qatar
      • 9.2.6.3.1. By Technology
      • 9.2.6.3.2. By Probe
      • 9.2.6.3.3. By Product
      • 9.2.6.3.4. By Application
      • 9.2.6.3.5. By End Use
      • 9.2.6.4. Kuwait
      • 9.2.6.4.1. By Technology
      • 9.2.6.4.2. By Probe
      • 9.2.6.4.3. By Product
      • 9.2.6.4.4. By Application
      • 9.2.6.4.5. By End Use
      • 9.2.6.5. South Africa
      • 9.2.6.5.1. By Technology
      • 9.2.6.5.2. By Probe
      • 9.2.6.5.3. By Product
      • 9.2.6.5.4. By Application
      • 9.2.6.5.5. By End Use
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Technology
      • 9.2.6.6.2. By Probe
      • 9.2.6.6.3. By Product
      • 9.2.6.6.4. By Application
      • 9.2.6.6.5. By End Use
      • 9.2.6.7. Algeria
      • 9.2.6.7.1. By Technology
      • 9.2.6.7.2. By Probe
      • 9.2.6.7.3. By Product
      • 9.2.6.7.4. By Application
      • 9.2.6.7.5. By End Use
      • 9.2.6.8. Rest of MEA
      • 9.2.6.8.1. By Technology
      • 9.2.6.8.2. By Probe
      • 9.2.6.8.3. By Product
      • 9.2.6.8.4. By Application
      • 9.2.6.8.5. By End Use

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global In-Situ Hybridization Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global In-Situ Hybridization Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc.
  • 12.2. Abbott (Abbott Molecular)
  • 12.3. PerkinElmer, Inc.
  • 12.4. BioView
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Merck KGaA
  • 12.7. Bio-Rad Laboratories, Inc.
  • 12.8. Oxford Gene Technology IP Limited
  • 12.9. Leica Biosystems Nussloch GmbH
  • 12.10. F. Hoffman-La Roche Limited
  • 12.11. NeoGenomics Laboratories, Inc.
  • 12.12. Advanced Cell Diagnostics, Inc.
  • 12.13. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations